MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturity of
short-term investments
$648,820K
Net cash provided by
investing activities
$13,460K
Canceled cashflow
$635,360K
Net (decrease)
increase in cash and cash...
$7,655K
Canceled cashflow
$5,805K
Proceeds from sale of
short-term investments
-$425,795K
Cash paid for
purchase of short-term...
$209,565K
Share-based compensation
expense
$9,561K
Accrued expenses and
other current...
$4,079K
Accounts receivable, net
-$2,972K
Amortization of intangible
assets
$795K
Accounts payable
$688K
Prepaid expenses and
other current assets
-$480K
Depreciation expense
$90K
Deferred revenue
$52K
Amortization of operating
right-of-use asset
$49K
Net cash used in
operating activities
-$5,805K
Canceled cashflow
$18,766K
Net loss
-$19,726K
Accretion of discounts on
short-term investments,...
$4,121K
Inventory
$480K
Deposits and other
long-term assets
$134K
Operating lease liability
-$110K
Back
Back
Cash Flow
Day One Biopharmaceuticals, Inc. (DAWN)
Day One Biopharmaceuticals, Inc. (DAWN)
source: myfinsight.com